Diagnosis, Treatment, and Long-Term Outcomes of Pediatric Pemphigus: A Retrospective Study at Tertiary Medical Centers

    Yael Renert‐Yuval, Sharon Baum, Shoshana Greenberger, Eran Cohen‐Barak, Meital Oren‐Shabtai, Dan Ben Amitai, Rivka Friedland
    Studysummary In this study, pediatric pemphigus was found to have a chronic but mostly benign progression, with initial remission from corticosteroids typically requiring additional immunomodulators for long-term control, and the authors advocate for using rituximab in these cases.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →